PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

April 23, 2024

https://www.globenewswire.com/news-release/2024/04/23/2867597/0/en/PROCEPT-BioRobotics-Announces-12-Scientific-Research-Presentations-on-Aquablation-Therapy-for-the-Treatment-of-Benign-Prostatic-Hyperplasia-at-the-2024-AUA-Annual-Meeting.html

SAN JOSE, Calif., April 23, 2024 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® Corporation (Nasdaq:PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that 12 abstracts highlighting its Aquablation therapy for the treatment of benign prostatic hyperplasia (BPH) will be presented at the American Urological Association (AUA) Annual Meeting in San Antonio, Texas, from May 3 – 6, 2024. PROCEPT BioRobotics is exhibiting at booth #1429 and will be conducting hands-on workshops and surgeon presentations throughout the meeting.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.